ICON PLC (ICLR) Fundamental Analysis & Valuation
NASDAQ:ICLR • IE0005711209
Current stock price
98.33 USD
+0.88 (+0.9%)
At close:
98.33 USD
0 (0%)
After Hours:
This ICLR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ICLR Profitability Analysis
1.1 Basic Checks
- ICLR had positive earnings in the past year.
- In the past year ICLR had a positive cash flow from operations.
- Each year in the past 5 years ICLR has been profitable.
- Each year in the past 5 years ICLR had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of ICLR (3.63%) is better than 73.68% of its industry peers.
- ICLR's Return On Equity of 6.42% is fine compared to the rest of the industry. ICLR outperforms 73.68% of its industry peers.
- The Return On Invested Capital of ICLR (6.74%) is better than 77.19% of its industry peers.
- ICLR had an Average Return On Invested Capital over the past 3 years of 5.80%. This is significantly below the industry average of 11.85%.
- The last Return On Invested Capital (6.74%) for ICLR is above the 3 year average (5.80%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROIC | 6.74% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
- Looking at the Profit Margin, with a value of 7.40%, ICLR is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
- In the last couple of years the Profit Margin of ICLR has declined.
- ICLR has a better Operating Margin (13.99%) than 75.44% of its industry peers.
- In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
- The Gross Margin of ICLR (28.15%) is worse than 77.19% of its industry peers.
- In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. ICLR Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICLR is destroying value.
- ICLR has less shares outstanding than it did 1 year ago.
- ICLR has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ICLR has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.55, we must say that ICLR is in the distress zone and has some risk of bankruptcy.
- ICLR has a Altman-Z score (1.55) which is in line with its industry peers.
- ICLR has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as ICLR would need 3.53 years to pay back of all of its debts.
- ICLR has a Debt to FCF ratio of 3.53. This is in the better half of the industry: ICLR outperforms 77.19% of its industry peers.
- A Debt/Equity ratio of 0.31 indicates that ICLR is not too dependend on debt financing.
- The Debt to Equity ratio of ICLR (0.31) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Altman-Z | 1.55 |
ROIC/WACC0.73
WACC9.17%
2.3 Liquidity
- A Current Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
- ICLR has a Current ratio of 1.06. This is amonst the worse of the industry: ICLR underperforms 85.96% of its industry peers.
- A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.06, ICLR is doing worse than 78.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. ICLR Growth Analysis
3.1 Past
- The earnings per share for ICLR have decreased by -5.99% in the last year.
- ICLR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.23% yearly.
- The Revenue has decreased by -2.46% in the past year.
- Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 24.17% on average per year.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
3.2 Future
- ICLR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.14% yearly.
- Based on estimates for the next years, ICLR will show a small growth in Revenue. The Revenue will grow by 1.48% on average per year.
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.22%
Revenue Next 5Y1.48%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. ICLR Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 7.45, the valuation of ICLR can be described as very cheap.
- 98.25% of the companies in the same industry are more expensive than ICLR, based on the Price/Earnings ratio.
- ICLR is valuated cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
- ICLR is valuated cheaply with a Price/Forward Earnings ratio of 7.65.
- ICLR's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 98.25% of the companies in the same industry.
- ICLR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.45 | ||
| Fwd PE | 7.65 |
4.2 Price Multiples
- 98.25% of the companies in the same industry are more expensive than ICLR, based on the Enterprise Value to EBITDA ratio.
- 98.25% of the companies in the same industry are more expensive than ICLR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.79 | ||
| EV/EBITDA | 6.82 |
4.3 Compensation for Growth
- ICLR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
5. ICLR Dividend Analysis
5.1 Amount
- No dividends for ICLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ICLR Fundamentals: All Metrics, Ratios and Statistics
98.33
+0.88 (+0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)04-30 2026-04-30/amc
Inst Owners108.2%
Inst Owner Change4.34%
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap7.51B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts74.17
Price Target159.5 (62.21%)
Short Float %2.65%
Short Ratio1.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)-23.93%
PT rev (3m)-23.97%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)-2.29%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.73%
Revenue NQ rev (1m)-0.49%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.45 | ||
| Fwd PE | 7.65 | ||
| P/S | 0.93 | ||
| P/FCF | 7.79 | ||
| P/OCF | 6.58 | ||
| P/B | 0.8 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.82 |
EPS(TTM)13.19
EY13.41%
EPS(NY)12.85
Fwd EY13.07%
FCF(TTM)12.63
FCFY12.84%
OCF(TTM)14.93
OCFY15.19%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.49
Graham Number190.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 6.42% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 6.98% | ||
| ROICexgc | 176.34% | ||
| OM | 13.99% | ||
| PM (TTM) | 7.4% | ||
| GM | 28.15% | ||
| FCFM | 11.9% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 3.53 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 45.31% | ||
| Cap/Sales | 2.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.92% | ||
| Profit Quality | 160.84% | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 1.55 |
F-Score6
WACC9.17%
ROIC/WACC0.73
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-5.37%
EPS Next 2Y-4.18%
EPS Next 3Y0.09%
EPS Next 5Y2.14%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.67%
Revenue Next 2Y-1.68%
Revenue Next 3Y0.22%
Revenue Next 5Y1.48%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year0.19%
EBIT Next 3Y0.21%
EBIT Next 5Y2.03%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%
ICON PLC / ICLR Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ICON PLC?
ChartMill assigns a fundamental rating of 5 / 10 to ICLR.
What is the valuation status for ICLR stock?
ChartMill assigns a valuation rating of 8 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.
How profitable is ICON PLC (ICLR) stock?
ICON PLC (ICLR) has a profitability rating of 6 / 10.
What is the valuation of ICON PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ICON PLC (ICLR) is 7.45 and the Price/Book (PB) ratio is 0.8.
How financially healthy is ICON PLC?
The financial health rating of ICON PLC (ICLR) is 4 / 10.